Monday, February 19, 2018
 
 
Company News: Page (1) of 1 - 09/12/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Bearded Villains of New England Raise Money for Greater Boston Walk to End Alzheimer's

(September 12, 2017)


"“We are more than a team or your typical fraternal organization,” says BVNE Charity Ambassador Bjorn Silvia. “We are brothers who are drawn together with the goal of elevating ourselves and making the world around us a better place.”"
On September 24, 2017 the Bearded Villains of New England “The Saints” will join thousands of other participants to raise awareness and money for Alzheimer’s research by participating in the Greater Boston Walk to End Alzheimer’s.

CAMBRIDGE, MASSACHUSETTS - On Sunday, September 24, 2017, the Alzheimer’s Association is sponsoring the 2017 Walk to End Alzheimer's Greater Boston Walk in Cambridge, MA. Among the dozens of participating teams and hundreds of individual participants will be members of the Bearded Villains of New England “The Saints,” a local fraternal organization. 

As of this writing, the Bearded Villains of New England have raised more than $3,700 toward Alzheimer’s research through their online team page, with 13 members and friends planning to participate in the walk.

“We are more than a team or your typical fraternal organization,” says BVNE Charity Ambassador Bjorn Silvia. “We are brothers who are drawn together with the goal of elevating ourselves and making the world around us a better place.”

More information about the 2017 Walk to End Alzheimer's Greater Boston Walk can be found on the event’s website here. Those who wish to donate to the Alzheimer’s Association can do so through the Bearded Villains of New England team page here.

About the Alzheimer’s Association

Founded in 1980, the Alzheimer’s Association is a national organization that provides support, education, and awareness of issues surrounding Alzheimer’s and dementia. This includes providing care and support for those afflicted with Alzheimer’s and their families, funding of research for new treatments, advocacy, volunteering and more.

The Walk to End Alzheimer’s is one of its flagship yearly events, and the world’s largest event to raise awareness and funds for Alzheimer’s disease care, support and research.

About the Bearded Villains

Founded in 2014 in Los Angeles, the Bearded Villains is a “brotherhood of elite bearded men from all over the world.” Bearded Villains chapters have formed worldwide, including in the U.S., Canada, Mexico, Australia, Germany, Greece, the Netherlands, and other nations across the globe.

Founded by KON, the Bearded Villains of New England “The Saints” is one of the fastest growing chapters in the United States, and has participated in fundraisers and other events in support of causes such as the CT Walk to Defeat ALS, the American Foundation for Suicide Prevention, the Autism Project Charity Walk, and more.

The Bearded Villains of New England shares its mission statement with the national organization: “To Unite Bearded Men of all cultures, races and creed in a Brotherhood devoted to Loyalty, Honor and Respect toward all peoples; Dedicated to the betterment of mankind through Fraternity, Charity and Kindness.”

Press Release Services by Keyword Performance

Media Contact

Company Name: Bearded Villains of New England Email: [email protected]


Country: United States
Website: http://www.bvnesaints.com/



Source: www.abnewswire.com


Page: 1


Related Keywords:Health & Medicine,Non Profit,Public Affairs,Society & Culture,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • BC Platforms to Provide Real World Evidence Solutions to Pfizer in Cardiovascular Diseases
  • Knee Bursitis Market 2018 | with ~7.1% of CAGR | A Definite Shift towards the Developing World | Forecasts till 2023
  • Worldwide Wound Closure Device Market is Expected to grow 21 billion by the end of the forecasted period, 2016-2022
  • Intralytix Receives FDA Clearance to Initiate Phase I / IIa Clinical Trials
  • Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration

    Cancer
  • Oasmia Pharmaceutical’s Docecal program achieves significant development milestone
  • PharmaMar Has Published the Results of Its Antibody Conjugate Active in Breast, Ovarian and Gastric Cancers that Express HER2
  • Digestive Center Launches ACTZYM, A Digestive Enzyme Designed to Optimize Overall Health and Wellness
  • Merrimack to Present at the 2018 RBC Capital Markets Global Healthcare Conference
  • MDxHealth Notice of Financial Year 2017 Results
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines